Stay updated on Secured Access to Nivolumab for Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Secured Access to Nivolumab for Rare Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T06:33:28.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer's revision label was updated from v3.7.0 to v3.7.1, while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T08:37:20.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.7.0' was added to the page to indicate the current interface version; several metadata terms and related sections were removed from the study record view, altering what appears on the page.
    Difference
    19%
    Check dated 2026-09-20T04:27:26.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The update adds a funding attribution line '2016 ( U.S. NIH Grant/Contract )' to the study's official identifiers and updates the page revision from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T23:43:54.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a minor frontend/software update and does not change any study content or data.
    Difference
    0.1%
    Check dated 2026-08-08T18:35:43.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Revision: v3.6.4 appears on the page, replacing v3.6.3. This indicates a small patch to the page's revision history and does not alter the study details shown.
    Difference
    0.1%
    Check dated 2026-07-25T10:43:03.000Z thumbnail image

Stay in the know with updates to Secured Access to Nivolumab for Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.